ICU Medical, Inc. (NASDAQ:ICUI) Shares Bought by Algert Global LLC

Algert Global LLC lifted its position in shares of ICU Medical, Inc. (NASDAQ:ICUI) by 16.9% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 6,370 shares of the medical instruments supplier’s stock after acquiring an additional 920 shares during the period. Algert Global LLC’s holdings in ICU Medical were worth $988,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. Barclays PLC lifted its position in shares of ICU Medical by 15.6% in the 3rd quarter. Barclays PLC now owns 59,207 shares of the medical instruments supplier’s stock worth $10,790,000 after buying an additional 8,010 shares during the last quarter. Principal Financial Group Inc. boosted its stake in ICU Medical by 24.6% in the third quarter. Principal Financial Group Inc. now owns 126,937 shares of the medical instruments supplier’s stock valued at $23,130,000 after acquiring an additional 25,031 shares during the period. Vanguard Group Inc. grew its holdings in shares of ICU Medical by 0.7% during the fourth quarter. Vanguard Group Inc. now owns 2,682,065 shares of the medical instruments supplier’s stock valued at $416,176,000 after purchasing an additional 17,805 shares during the last quarter. Jennison Associates LLC acquired a new stake in shares of ICU Medical during the 4th quarter worth approximately $556,000. Finally, Franklin Resources Inc. lifted its holdings in shares of ICU Medical by 99.3% in the 3rd quarter. Franklin Resources Inc. now owns 11,708 shares of the medical instruments supplier’s stock worth $2,111,000 after purchasing an additional 5,834 shares during the last quarter. 96.10% of the stock is owned by institutional investors and hedge funds.

ICU Medical Stock Down 3.2 %

ICUI stock opened at $138.30 on Friday. The firm’s 50-day moving average is $140.67 and its two-hundred day moving average is $155.13. The company has a current ratio of 2.29, a quick ratio of 1.03 and a debt-to-equity ratio of 0.75. The company has a market capitalization of $3.40 billion, a price-to-earnings ratio of -30.26 and a beta of 0.87. ICU Medical, Inc. has a 52 week low of $100.91 and a 52 week high of $196.26.

ICU Medical (NASDAQ:ICUI) last issued its quarterly earnings results on Thursday, May 8th. The medical instruments supplier reported $1.72 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.23 by $0.49. ICU Medical had a positive return on equity of 5.05% and a negative net margin of 4.74%. The firm had revenue of $599.49 million during the quarter, compared to analyst estimates of $574.15 million. During the same period last year, the company posted $0.96 EPS. The firm’s quarterly revenue was up 6.7% on a year-over-year basis. On average, analysts forecast that ICU Medical, Inc. will post 4.11 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on ICUI shares. Raymond James dropped their target price on ICU Medical from $197.00 to $187.00 and set a “strong-buy” rating on the stock in a research report on Friday. KeyCorp cut their price objective on shares of ICU Medical from $209.00 to $191.00 and set an “overweight” rating on the stock in a research report on Monday, April 21st. StockNews.com lowered shares of ICU Medical from a “buy” rating to a “hold” rating in a research note on Saturday. Finally, Needham & Company LLC reiterated a “hold” rating on shares of ICU Medical in a research report on Tuesday, April 8th. Two investment analysts have rated the stock with a hold rating, two have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $192.67.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.